Belvedere Trading LLC Xenon Pharmaceuticals Inc. Call Options Transaction History

Belvedere Trading LLC

  • $74.4 Billion
  • Q3 2024

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Oct 27, 2023
SELL
$34.16 - $39.73 $174,215 - $202,622
-5,100 Reduced 52.04%
4,700 $160,000
Q2 2023

Aug 08, 2023
BUY
$34.84 - $43.54 $153,296 - $191,576
4,400 Added 81.48%
9,800 $377,000
Q1 2023

May 15, 2023
BUY
$33.46 - $40.35 $180,684 - $217,890
5,400 New
5,400 $193,000
Q4 2021

Jan 25, 2022
SELL
$15.6 - $35.4 $184,080 - $417,720
-11,800 Closed
0 $0
Q3 2021

Oct 19, 2021
BUY
$14.86 - $19.45 $175,348 - $229,510
11,800 New
11,800 $362,000

Others Institutions Holding XENE

# of Institutions
212
Shares Held
70.2M
Call Options Held
88.3K
Put Options Held
28.8K
View Full List

About Xenon Pharmaceuticals Inc.

XENE Quotes by TradingView
  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.39B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email